These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 26398882)

  • 21. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.
    Li W; Xie L; He X; Li J; Tu K; Wei L; Wu J; Guo Y; Ma X; Zhang P; Pan Z; Hu X; Zhao Y; Xie H; Jiang G; Chen T; Wang J; Zheng S; Cheng J; Wan D; Yang S; Li Y; Gu J
    Int J Cancer; 2008 Oct; 123(7):1616-22. PubMed ID: 18649363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
    Giordano S; Columbano A
    Hepatology; 2013 Feb; 57(2):840-7. PubMed ID: 23081718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.
    Chen SP; Liu BX; Xu J; Pei XF; Liao YJ; Yuan F; Zheng F
    BMC Cancer; 2015 Oct; 15():706. PubMed ID: 26471185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
    Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
    Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs Contribute to Hepatocellular Carcinoma.
    Song Y; Wang F; Huang Q; Cao Y; Zhao Y; Yang C
    Mini Rev Med Chem; 2015; 15(6):459-66. PubMed ID: 25807945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.
    Borel F; Konstantinova P; Jansen PL
    J Hepatol; 2012 Jun; 56(6):1371-83. PubMed ID: 22314424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Goldani F; Parizadeh SMR; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Avan A
    Curr Drug Targets; 2019; 20(11):1129-1140. PubMed ID: 30848198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.
    Sun J; Lu H; Wang X; Jin H
    ScientificWorldJournal; 2013; 2013():924206. PubMed ID: 23431261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma.
    Shaker O; Alhelf M; Morcos G; Elsharkawy A
    Infect Genet Evol; 2017 Jul; 51():173-181. PubMed ID: 28366737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-99b promotes metastasis of hepatocellular carcinoma through inhibition of claudin 11 expression and may serve as a prognostic marker.
    Yang J; Liu X; Yuan X; Wang Z
    Oncol Rep; 2015 Sep; 34(3):1415-23. PubMed ID: 26134929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.
    Li S; Yao J; Xie M; Liu Y; Zheng M
    J Hematol Oncol; 2018 Apr; 11(1):54. PubMed ID: 29642941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
    Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
    Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis.
    Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J
    J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review.
    Guo G; Zhou J; Yang X; Feng J; Shao Y; Jia T; Huang Q; Li Y; Zhong Y; Nagarkatti PS; Nagarkatti M
    Integr Cancer Ther; 2018 Dec; 17(4):1059-1067. PubMed ID: 30343602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of MicroRNA in the Diagnosis and Management of Hepatocellular Carcinoma.
    Ziogas IA; Sioutas G; Mylonas KS; Tsoulfas G
    Microrna; 2020; 9(1):25-40. PubMed ID: 31218966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.